Latest Period
Q2 2026
Security Snapshot
Evolent Health, Inc. - Class A Stock (EVH) Institutional Ownership
CUSIP: 30050B101
13F Institutional Holders and Ownership History from Q2 2015 to Q2 2026
Institutions Reporting
198
Shares (Excl. Options)
112,182,620
Price
$5.42
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Class A Stock
- Symbol
- EVH on NYSE
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 112,182,620
- Total 13F value
- $608,066,826
- Portfolio coverage rank
- 0%
- Share change
- +1,199,869
- Value change
- +$35,701,052
- Number of holders
- 198
- Shares outstanding
- 113,224,636
- SEC-reported price per share
- $4.66
- Insider filing price
- $4.66
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- EVH - Evolent Health, Inc. - Class A Stock is tracked under CUSIP 30050B101.
- 198 institutions reported positions in Q2 2026.
- 9 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 187 to 198 between Q1 2026 and Q2 2026.
- SEC-reported value moved from $252,228,979 to $608,066,826.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 198 institutions filings for Q2 2026.
Security key
30050B101
Latest holder period
Q2 2026
13F holders
198
13D/G owners
9
CIK / CUSIP context first
Open Q2 2026 holders
EVH full holder history
Evolent Health, Inc. SEC filings
Evolent Health, Inc. company facts
Evolent Health, Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 30050B101:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
9
Security
EVH
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| CADIAN CAPITAL MANAGEMENT, LP | 9.3% | $106,218,923 | 10,794,606 | Cadian Capital Management, LP | 31 Mar 2025 | |||
| MORGAN STANLEY | 8.1% | +16% | $37,755,903 | +$3,682,702 | 9,097,808 | +11% | Morgan Stanley | 31 Dec 2025 |
| VANGUARD GROUP INC | 8% | $35,656,260 | 8,914,065 | The Vanguard Group | 31 Dec 2025 | |||
| BlackRock Portfolio Management LLC | 5.5% | $33,752,264 | 6,227,355 | BlackRock Portfolio Management LLC | 30 Jun 2026 | |||
| Boehler Adam | 5.2% | $49,204,401 | 5,816,123 | Rubicon OP GP II LP | 13 Nov 2025 | |||
| RA CAPITAL MANAGEMENT, L.P. | 3.1% | $35,199,618 | 3,577,197 | RA Capital Management, L.P. | 31 Dec 2024 | |||
| FMR LLC | 0.7% | -91% | $3,003,548 | -$34,663,704 | 750,887 | -92% | FMR LLC | 31 Dec 2025 |
| WELLINGTON MANAGEMENT GROUP LLP | 0.4% | -96% | $5,016,947 | -$113,228,542 | 442,802 | -96% | Wellington Management Group LLP | 30 Jun 2025 |
| EVENTIDE ASSET MANAGEMENT, LLC | 0% | -108% | $7,109 | -$26,106,812 | 1,713 | -100% | Eventide Asset Management, LLC | 31 Dec 2025 |
As of 30 Jun 2026, 198 institutional investors reported holding 112,182,620 shares of Evolent Health, Inc. - Class A Stock (EVH). This represents 99% of the company’s total 113,224,636 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
82%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| BlackRock, Inc. | 13% | 14,814,851 | +36% | 0% | $80,296,492 |
| CADIAN CAPITAL MANAGEMENT, LP | 9.6% | 10,814,473 | 0% | 4.4% | $58,614,444 |
| MORGAN STANLEY | 7.9% | 8,969,012 | -1.2% | 0% | $48,612,048 |
| UBS Group AG | 5.5% | 6,245,283 | -23% | 0.01% | $33,849,434 |
| Rubicon Founders LLC | 5.1% | 5,816,123 | 0% | 16% | $31,523,387 |
| Engaged Capital LLC | 4.9% | 5,563,912 | 0% | 9.2% | $30,156,403 |
| D. E. Shaw & Co., Inc. | 4.5% | 5,107,561 | -6% | 0.02% | $27,682,981 |
| VANGUARD CAPITAL MANAGEMENT LLC | 4.2% | 4,787,994 | -1.6% | 0% | $25,950,927 |
| MARSHALL WACE, LLP | 3% | 3,413,245 | +335% | 0.02% | $18,499,786 |
| Nuveen, LLC | 2.8% | 3,132,085 | +1081% | 0% | $16,975,900 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.6% | 2,904,912 | +11% | 0% | $15,748,879 |
| Rock Springs Capital Management LP | 2.2% | 2,500,000 | -6.5% | 0.66% | $13,550,000 |
| STATE STREET CORP | 2.2% | 2,460,431 | -7% | 0% | $13,335,536 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1.9% | 2,131,573 | +9.3% | 0% | $11,553,126 |
| GOLDMAN SACHS GROUP INC | 1.5% | 1,745,852 | -22% | 0% | $9,462,518 |
| Rock Point Advisors, LLC | 1.5% | 1,719,886 | -3.7% | 2.3% | $9,321,782 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 1.4% | 1,601,638 | +163% | 0.03% | $8,680,878 |
| KENNEDY CAPITAL MANAGEMENT LLC | 1.4% | 1,567,816 | -1.9% | 0.15% | $8,497,563 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 1.2% | 1,347,822 | +45% | 0% | $7,305,195 |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | 1.1% | 1,276,800 | 0.01% | $6,920,256 | |
| TWO SIGMA INVESTMENTS, LP | 1.1% | 1,263,653 | +45% | 0.01% | $6,848,999 |
| NORTHERN TRUST CORP | 0.89% | 1,003,245 | +9.4% | 0% | $5,437,589 |
| Hudson Bay Capital Management LP | 0.81% | 913,109 | -31% | 0.02% | $4,949,051 |
| BANK OF AMERICA CORP /DE/ | 0.77% | 875,398 | +212% | 0% | $4,744,657 |
| BNP PARIBAS FINANCIAL MARKETS | 0.76% | 860,358 | 0% | 0% | $4,663,140 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
45
Latest
Q2 2026
Rows shown
1-25 of 45
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q2 | 112,182,620 | $608,066,826 | +$35,701,052 | $5.42 | 198 |
| 2026 Q1 | 110,648,720 | $252,228,979 | -$29,546,930 | $2.28 | 187 |
| 2025 Q4 | 120,528,845 | $482,118,879 | -$146,972,693 | $4.00 | 212 |
| 2025 Q3 | 135,659,696 | $1,147,817,881 | +$12,305,118 | $8.46 | 237 |
| 2025 Q2 | 131,673,312 | $1,482,570,130 | +$78,519,495 | $11.26 | 218 |
| 2025 Q1 | 125,716,823 | $1,190,564,177 | +$20,137,898 | $9.47 | 222 |
| 2024 Q4 | 122,283,963 | $1,375,271,472 | -$248,054,960 | $11.25 | 237 |
| 2024 Q3 | 129,270,440 | $3,653,744,995 | +$36,997,360 | $28.28 | 255 |
| 2024 Q2 | 129,502,142 | $2,475,760,428 | +$40,167,326 | $19.12 | 239 |
| 2024 Q1 | 125,850,762 | $4,125,692,137 | -$4,762,881 | $32.79 | 247 |
| 2023 Q4 | 126,464,041 | $4,176,843,783 | +$156,108,720 | $33.03 | 232 |
| 2023 Q3 | 122,189,782 | $3,342,247,641 | +$125,298,418 | $27.23 | 201 |
| 2023 Q2 | 117,663,348 | $3,553,501,314 | +$168,830,769 | $30.30 | 216 |
| 2023 Q1 | 111,825,275 | $3,615,108,333 | +$350,007,462 | $32.45 | 237 |
| 2022 Q4 | 101,432,734 | $2,846,879,147 | +$146,714,497 | $28.08 | 229 |
| 2022 Q3 | 95,515,991 | $3,431,522,864 | +$214,834,478 | $35.93 | 243 |
| 2022 Q2 | 89,722,827 | $2,755,609,040 | +$99,219,171 | $30.71 | 207 |
| 2022 Q1 | 86,524,226 | $2,793,511,290 | +$66,700,981 | $32.30 | 208 |
| 2021 Q4 | 84,687,344 | $2,342,026,098 | -$26,236,636 | $27.67 | 200 |
| 2021 Q3 | 85,614,905 | $2,649,865,771 | +$83,228,566 | $31.00 | 205 |
| 2021 Q2 | 83,046,124 | $1,753,120,165 | +$24,126,478 | $21.12 | 175 |
| 2021 Q1 | 81,962,439 | $1,657,194,786 | +$54,461,956 | $20.20 | 163 |
| 2020 Q4 | 81,531,166 | $1,307,117,041 | +$30,502,553 | $16.03 | 153 |
| 2020 Q3 | 79,968,182 | $996,864,007 | +$91,919,009 | $12.41 | 147 |
| 2020 Q2 | 73,419,664 | $521,944,449 | -$8,509,221 | $7.12 | 127 |